26 May 2013
Keywords: promising, ph, ii, data, abbott, abt-874, results
Article | 22 November 2004
Results reported in the New England Journal of Medicine suggest that Abbot Laboratories' ABT-874, a fully-human anti-interleukin-12
monoclonal antibody, may ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 November 2004
15 November 2004
24 May 2013
© 2013 thepharmaletter.com